← Back to headlines
CytomX Therapeutics Prices $250M Public Offering at $5.30 Per Share
CytomX Therapeutics has priced its public offering of $250 million worth of shares at $5.30 per share.
18 Mar, 05:39 — 18 Mar, 05:39
Sources
Showing 1 of 1 sources



